Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses: antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action; new or improved vaccines against viral infections of humans; assessments of drug and vaccine safety; evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures; identification and validation of new drug targets; laboratory animal models of viral diseases; pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.
抗病毒研究出版关于控制人类和动物病毒感染的研究报告、简短通讯、评论文章和评论。其范围包括：抗病毒药物、抗体和宿主反应调节剂，包括它们的合成、体外和体内测试以及作用机制;抗人类病毒感染的新的或改进的疫苗;药物和疫苗安全性评估;抗药性或疫苗抗药性病毒的演变和制定有效对策;新药物靶标的识别和验证;病毒性疾病的实验室动物模型;病毒性疾病的发病机理和病毒逃避宿主免疫应答的机制。
Antivirals targeting the polymerase complex of influenza viruses.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104545
In vitro comparison of currently available and investigational antiviral agents against pathogenic human double‐stranded DNA viruses: A systematic literature review
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2019.01.008
Antiviral activity of pinocembrin against Zika virus replication.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.04.003
Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.04.011
RA‐839, a selective agonist of Nrf2/ARE pathway, exerts potent anti‐rotaviral efficacy in vitro
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.11.009
Inhibition of a novel coumarin on an aquatic rhabdovirus by targeting the early stage of viral infection demonstrates potential application in aquaculture.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104672
Non-invasive biomarkers for chronic hepatitis B virus infection management.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104553
Vaccinating against monkeypox in the Democratic Republic of the Congo.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2018.11.004
In vivo proof‐of‐concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.11.008
Drug repurposing of N‐acetyl cysteine as antiviral against dengue virus infection
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2019.03.011
Tomatidine, a novel antiviral compound towards dengue virus
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.11.011
HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104619
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104613
Inhibition of HBV replication by N‐hydroxyisoquinolinedione and N‐hydroxypyridinedione ribonuclease H inhibitors
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2019.02.005
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104694
A novel RSV F‐Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2019.02.017
Encephalomyocarditis virus 2C protein antagonizes interferon‐&bgr; signaling pathway through interaction with MDA5
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.10.010
Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104641
Emetine protects mice from enterovirus infection by inhibiting viral translation.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104650
An endogenous retroviral element exerts an antiviral innate immune function via the derived lncRNA lnc-ALVE1-AS1.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104571
Prevalence of the entecavir‐resistance‐inducing mutation rtA186T in a large cohort of Chinese hepatitis B virus patients
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2019.02.012
Potent and broad‐spectrum cycloheptathiophene‐3‐carboxamide compounds that target the PA‐PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2019.03.003
Genetic stability of live-attenuated Zika vaccine candidates.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104596
FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104588
Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104676
A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.11.001
Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104616
Antiviral effects of selected nucleoside analogues against human parechoviruses A1 and A3.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2018.12.009
Clinical evidence for the immunogenicity and immune persistence of vaccination with yellow fever virus strain 17D in Chinese peacekeepers deployed to Africa.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2018.12.001
Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer‐based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.12.010
Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104573
In silico drug repurposing for the identification of potential candidate molecules against arboviruses infection.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104668
A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104544
Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.12.015
Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.05.009
An E. coli‐produced single‐chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.12.019
Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104643
Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8+ T cell responses in naïve and persistently infected mice and protects from challenge.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.05.014
Cat flu: Broad spectrum polymeric antivirals.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104563
The optimized fusion protein HA1–2‐FliC&Dgr;D2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.10.027
Anti-HBV activity of retinoid drugs in vitro versus in vivo.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104538
Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infection.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104617
Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104542
Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.06.004
Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104540
The role of miR‐409‐3p in regulation of HPV16/18‐E6 mRNA in human cervical high‐grade squamous intraepithelial lesions
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2019.01.019
Protection of swine by potent neutralizing anti-Japanese encephalitis virus monoclonal antibodies derived from vaccination.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104675
Fully galactosyl‐fucosyl‐bisected IgG1 reduces anti‐HBV efficacy and liver histological improvement
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.12.021
Discovery of 4‐oxoquinolines, a new chemical class of anti‐HIV‐1 compounds
来源期刊：Antiviral ResearchDOI：10.1016/j.antiviral.2018.12.012
Susceptibility of Enterovirus-D68 to RNAi-mediated antiviral knockdown.
来源期刊：Antiviral researchDOI：10.1016/j.antiviral.2019.104565
